GammaGA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GammaGA, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma